Diasorin SpA (MIL:DIA) Total Equity : €1,538 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Total Equity?

Diasorin SpA's total equity for the quarter that ended in Dec. 2023 was €1,538 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Diasorin SpA Total Equity Historical Data

The historical data trend for Diasorin SpA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Total Equity Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

848.62

956.32

1,367.94

1,519.75

1,537.97

Diasorin SpA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															1,519.75	1,527.20	1,495.70	1,554.00	1,537.97

Diasorin SpA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Diasorin SpA's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	3211.439	-	1673.471
	=	1,538

Diasorin SpA's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	3211.439	-	1673.471
	=	1,538

Diasorin SpA Total Equity Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (MIL:DIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

DSRLF:USA 0GZX:UK 34D:Germany

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.